Saturday, August 24News That Matters

Outside the Box: FDA needs to loosen up on CBD but clamp down on quality claims

Creatively: Food and drug administration must release on CBD but clamp lower on quality claims

Enhance consumer protections by creating product quality-assurance standards, not by restricting use of CBD.

Find Out More…



Outside The Box: FDA Needs To Loosen Up On CBD But Clamp Down On Quality Claims
Outside The Box: FDA Needs To Loosen Up On CBD But Clamp Down On Quality Claims
Outside The Box: FDA Needs To Loosen Up On CBD But Clamp Down On Quality Claims
Outside The Box: FDA Needs To Loosen Up On CBD But Clamp Down On Quality Claims

Outside The Box: FDA Needs To Loosen Up On CBD But Clamp Down On Quality Claims

Outside The Box: FDA Needs To Loosen Up On CBD But Clamp Down On Quality Claims

Leave a Reply

Your email address will not be published. Required fields are marked *